These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 19329037)
1. [Treatment of non-muscle infiltrating tumours of the bladder]. Irani J Prog Urol; 2009 Apr; 19(4):248-53. PubMed ID: 19329037 [No Abstract] [Full Text] [Related]
2. Intensive intravesical mitomycin C therapy in non-muscle-invasive bladder cancer: a dose intensity approach. Racioppi M; Volpe A; Cappa E; D'Agostino D; Pinto F; D'Addessi A; Sacco E; Bassi P Urol Int; 2010; 85(3):266-9. PubMed ID: 20516670 [TBL] [Abstract][Full Text] [Related]
3. Single instillation of mitomycin C reduces 1st year recurrence following transurethral resection of non-muscle invasive bladder cancer. Ather MH; Aziz S; Sulaiman MN J Ayub Med Coll Abbottabad; 2007; 19(4):18-20. PubMed ID: 18693589 [TBL] [Abstract][Full Text] [Related]
4. Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection. Shapiro O; Jones K; Wang C; Landas S; Haas GP Can J Urol; 2006 Dec; 13(6):3317-20. PubMed ID: 17187694 [TBL] [Abstract][Full Text] [Related]
5. Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma. Kalsi J; Harland SJ; Feneley MR Expert Opin Drug Deliv; 2008 Jan; 5(1):137-45. PubMed ID: 18095933 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic options in the management of intermediate-risk nonmuscle-invasive bladder cancer. Horvath A; Mostafid H BJU Int; 2009 Mar; 103(6):726-9. PubMed ID: 19007379 [TBL] [Abstract][Full Text] [Related]
7. [Postoperative and adjuvant intravesical therapy of superficial bladder tumours. Clinical practice and applied therapeutic agents]. Lingnau A; Miller K; Steiner U; Jentzmik F; Weikert S; Schostak M Aktuelle Urol; 2009 Sep; 40(5):307-9. PubMed ID: 19637135 [TBL] [Abstract][Full Text] [Related]
8. Re: A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. Stewart AB; Mostafid H J Urol; 2005 Apr; 173(4):1433; author reply 1433. PubMed ID: 15758827 [No Abstract] [Full Text] [Related]
9. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment? Sylvester RJ Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437 [No Abstract] [Full Text] [Related]
10. [Early postoperative mitomycin C instillation: when and how?]. Traxer O; Gattegno B Prog Urol; 2004 Apr; 14(2):249-51. PubMed ID: 15217151 [TBL] [Abstract][Full Text] [Related]
11. Management of superficial bladder cancer: what is new? Malmström PU Curr Opin Urol; 2000 Sep; 10(5):447-51. PubMed ID: 11005450 [TBL] [Abstract][Full Text] [Related]
12. Re: methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial. Masters JR J Natl Cancer Inst; 2001 Oct; 93(20):1574-5. PubMed ID: 11604485 [No Abstract] [Full Text] [Related]
13. Recurrency rate influencing effect on intravesical Lycurim treatment in transurethrally resected bladder tumours. Kondás J; Szentgyörgyi E Ther Hung; 1983; 31(2):55-8. PubMed ID: 6571182 [No Abstract] [Full Text] [Related]